Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
Most areas see acceptable Halloween conditions, but Houston, New England face storms.
Federal judges order USDA to use contingency funds to continue partial SNAP benefits amid government shutdown, but delays in processing could still leave vulnerable households without immediate help.
Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
Most areas see acceptable Halloween conditions, but Houston, New England face storms.
Federal judges order USDA to use contingency funds to continue partial SNAP benefits amid government shutdown, but delays in processing could still leave vulnerable households without immediate help.
